𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of the clinically negative neck in early-stage head and neck cancers after transoral resection

✍ Scribed by Juan P. Rodrigo; Jatin P. Shah; Carl E. Silver; Jesus E. Medina; Robert P. Takes; K. Thomas Robbins; Alessandra Rinaldo; Jochen A. Werner; Alfio Ferlito


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
126 KB
Volume
33
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The decision regarding treatment of the clinically negative neck has been debated extensively. This is particularly true with early‐stage tumors for which surgery is the treatment of choice, and the tumor has been resected transorally without a cervical incision. Elective neck dissection in this situation is an additional procedure with potential associated morbidity. The alternative strategy for the clinically negative neck is to β€œwait and watch.” Both an elective neck dissection policy and a β€œwatchful waiting” policy have their proponents. The purpose of this article was for us to review the literature about this subject to try to answer the following question: if the tumor has been resected transorally, should an elective treatment of the neck be performed or is a β€œwatchful waiting” policy safe and adequate? We conclude that, currently, the best available evidence suggests that elective neck dissection does not seem to be superior to the policy of observation without neck surgery, with regard to survival and control of neck disease. This review highlights the need for further well‐designed prospective studies that will provide more reliable answers to the debatable issue of the management of the clinically negative neck in such cases. Β© 2010 Wiley Periodicals, Inc. Head Neck, 2011


πŸ“œ SIMILAR VOLUMES


Management of the neck after alternating
✍ Giuseppe Sanguineti; Renzo Corvo; Marco Benasso; Giovanni Margarino; MariaPia So πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

Background. To investigate neck control probability and the value of nodal response at completion of alternating chemoradiotherapy, a group of 43 patients was reviewed. Methods. Patients were treated with 60 Gy alternated with four cycles of cisplatin and fluorouracil. All patients had lymph nodes

Transoral robotic surgery for the manage
✍ Eric M. Genden; Shaun Desai; Chih-Kwang Sung πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 160 KB πŸ‘ 1 views

## Abstract ## Background. The aim of this prospective study was to determine the technical feasibility, safety, and efficacy of transoral robotic surgery (TORS) for a variety of malignant head and neck lesions. ## Methods. From April 2007 to November 2007, 20 patients were enrolled in an instit

Selective neck dissection in the managem
✍ Marc Hamoir; C.RenΓ© Leemans; Gilles Dolivet; Sandra Schmitz; Vincent GrΓ©goire; G πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

## Abstract For patients with advanced regional disease, neck dissection following (chemo)radiotherapy remains controversial. Selective neck dissection (SND) was reported as suitable after chemoradiation in patients with advanced regional disease. Reduced morbidity represents the major advantage of

The role of dental evaluation in head an
✍ Nahum, Alan M. πŸ“‚ Article πŸ“… 1980 πŸ› Wiley (John Wiley & Sons) βš– 58 KB πŸ‘ 2 views

Cancer of the head and neck arises most often from body surfaces that have been exposed to deleterious environmental influences. These body surfaces include the skin and the linings of the air and food passages. Solar radiation, alcohol, and tobacco are currently at the top of the list of the damagi

Management of the neck in a randomized t
✍ Pierre Lavertu; David J. Adelstein; Jerrold P. Saxton; Michelle Secic; John R. W πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

Background. Treating the neck after organpreservation treatment with radiotherapy or chemoradiotherapy can be problematic. Methods. To develop management guidelines, we reviewed the results of a 100-patient phase-3 trial that had compared outcome after radiotherapy alone with outcome after chemorad